Grants per year
Search results
-
Finished
Prot #CX-659-401: A Phase 2 Study of Mivavotinib in Biomarker-Defined Subgroups of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Karmali, R. (PD/PI)
9/7/22 → 3/31/23
Project: Research project
-
Prot #TAK-007-2001: A Phase 2, Open-label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Karmali, R. (PD/PI)
PPD Investigator Services, LLC, Takeda Development Center Americas, Inc.
6/10/22 → 6/10/25
Project: Research project
-
Prot #RPM-CART-001: An Observational Study to Evaluate a Temperature Monitoring Device in Subjects Receiving CAR-T Therapy
Karmali, R. (PD/PI)
9/28/20 → 9/28/23
Project: Research project
-
Prot #NDS-NHL-001: A Global, Non-Interventional, Retrospective, Multi-Center Study To Generate Real-World Evidence Of Treatment Outcomes In Subjects With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Karmali, R. (PD/PI)
Quintiles, Inc., Celgene Corporation
9/18/19 → 9/18/24
Project: Research project
-
Prot #NEER-01: Network for Enigmatic Exceptional Responders to Cancer Treatment - The Cure is NEER
Karmali, R. (PD/PI)
Takeda Pharmaceuticals U.S.A., Inc., Millennium Pharmaceuticals, Inc.
6/12/19 → 6/12/22
Project: Research project
-
Prot #GC-LTFU-001: Long-term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells
Karmali, R. (PD/PI)
ICON Clinical Research, LLC, Celgene Corporation
1/8/19 → 1/8/25
Project: Research project
-
Prot #ASTX660-01: Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects with Advanced Solid Tumors and Lymphomas
Karmali, R. (PD/PI) & Pro, B. (PD/PI)
10/17/18 → 10/17/24
Project: Research project
-
Prot #KTE-C19-107: A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel versus Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)
Karmali, R. (PD/PI)
DrugDev Inc., Kite Pharma, Inc.
10/12/18 → 10/12/23
Project: Research project
-
Prot #D8540C00001: A Phase 1 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Antitumor Activity of MEDI7247 in Patients with Selected Relapsed/R
Karmali, R. (PD/PI)
3/7/18 → 3/7/23
Project: Research project
-
Prot #VT3996-201: A Phase 1b/2 Open-Label, Dose Escalation and Expansion Study of Orally Administered VRx-3996 and Valganciclovir in Subjects with Epstein-Barr Virus-Associated Lymphoid Malignancies
Karmali, R. (PD/PI)
CTI Clinical Trial and Consulting Services, Viracta Therapeutics, Inc.
2/23/18 → 2/23/24
Project: Research project
-
Impact of Cachexia on Clinical Outcomes in Aggressive Lymphomas
Karmali, R. (PD/PI)
9/1/16 → 6/15/19
Project: Research project
-
Prot #INCB 52793-101: A Phase 1a/1b, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies
Karmali, R. (PD/PI) & Kaplan, J. B. (Other)
12/2/15 → 12/2/18
Project: Research project
-
Prot #INCB 54329-101: Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054329 in Subjects With Advanced Malignancies
Karmali, R. (PD/PI) & Kaplan, J. B. (Other)
Covance Inc., Incyte Corporation
9/11/15 → 9/11/18
Project: Research project
-
Prot #PCI-32765MCL2003: NU 14H06: A Phase II Clinical Trial Evaluating Ibrutinib Maintenance Following Intensive Induction for Patients with Previously Untreated Mantle Cell Lymphoma (MCL)
Karmali, R. (PD/PI), Kaplan, J. B. (Other) & Pro, B. (Other)
Janssen Scientific Affairs, LLC
1/6/15 → 1/6/25
Project: Research project
-
Prot #KCP-330-009: A Phase 2b Open-label, Randomized Two-arm Study of Selinexor (KPT-330) with Low Dose Dexamethasone in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Karmali, R. (PD/PI) & Kaplan, J. B. (Other)
Clinipace, Inc., Karyopharm Therapeutics Inc.
12/23/14 → 12/23/20
Project: Research project
-
Prot #C34001: An Open-Label, Dose Escalation, Phase 1, First-in-Human Study of TAK-659 in Adult Patients with Advanced Solid Tumor and Lymphoma Malignancies
Karmali, R. (PD/PI) & Kaplan, J. B. (Other)
Millennium Pharmaceuticals, Inc.
1/23/14 → 1/23/23
Project: Research project
-
Prot #CC-122-DLBCL-001: A Phase 1B, Multi-Center, Open Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma
Karmali, R. (PD/PI) & Kaplan, J. B. (Other)
9/17/13 → 9/17/19
Project: Research project